Cost-effectiveness and ROI of a Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands; Early Prostacyclin Therapy and ECLS Use in Patients With Congenital Diaphragmatic Hernia

05/06/2023 16 min
Cost-effectiveness and ROI of a Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands; Early Prostacyclin Therapy and ECLS Use in Patients With Congenital Diaphragmatic Hernia

Listen "Cost-effectiveness and ROI of a Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands; Early Prostacyclin Therapy and ECLS Use in Patients With Congenital Diaphragmatic Hernia"

Episode Synopsis

JAMA Pediatrics Editors' Summary by Dimitri A. Christakis, MD, MPH, Editor in Chief, and Alison A. Galbraith, MD, MPH, Associate Editor, for the June 6, 2023, issue. Related Content: Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands Association Between Early Prostacyclin Therapy and Extracorporeal Life Support Use in Patients With Congenital Diaphragmatic Hernia

More episodes of the podcast JAMA Pediatrics Editors' Summary